We're sorry. An error has occurred
Please cancel or retry.
Approaching Global Oncology
Some error occured while loading the Quick View. Please close the Quick View and try reloading the page.
Couldn't load pickup availability
- Format:
-
10 June 2022

The gap between the required and the available cancer care in the world widened in the last decade for the majority of cancer patients in the world. The Editors and experts who contributed to this book present how there is a need for global approaches and campaign for the scientific exploration of avenues to increase affordability of better value cancer treatment for millions of cancer patients in the world. They do so while considering the interests and incentives of all stakeholders in the real world, including first cancer patients everywhere, governments, professional cancer care providers, health industries, health business and economy. All would win. The scope is global. This book is just one of many efforts to spread the idea of the win-win movement.
The book is honoured with special contribution of the late Dr. Tabaré Vázquez, immediate past president of the republic of Uruguay, A keynote by HRH Princess Dina Mired and a foreword by Sir Muir Gray.
Key Features:
- Extensively covers the win-win approaches for global oncology as an important component of global health.
- Covers the win or benefits for institutions for participation in global health
- Provides Examples of win-win initiatives for global oncology
- Provides perspectives from renowned international experts, editors of high impact international journals and authors, governments, youth advocates/residents, industry, diaspora, and others looking to ‘win’ in global oncology and health
MEDICAL / Oncology / General, Oncology, MEDICAL / Health Policy, MEDICAL / Radiology, Radiotherapy & Nuclear Medicine, Radiotherapy, Medical physics
"What brilliant work" - Annie Young, Emerita Professor of Nursing, Warwick Medical School.
Chapter 18 - Research reported in this chapter was supported, in
part, by grants from Varian Medical Systems, Inc and the National Cancer Institute of
the National Institutes of Health under award number R01CA188446. The content is solely the
responsibility of the authors and does not necessarily represent the official views of the
National Institutes of Health.